Tagviral suppression

Client-led care in HIV: perspectives from community and practice

C

Crawford, D, Allan, B, Cogle, A, Brown, G. Client-led care in HIV: perspectives from community and practice. HIV Med. 2021; 22 (Suppl 1): 3– 14.  While current antiretroviral and care strategies can effectively suppress HIV, achieving optimal quality of life (QoL) requires a wider consideration of clients’ well-being, the complexity of individuals’ lives and social determinants of health. The...

Consensus statement on the role of health systems in advancing the long-term well-being of PLHIV

C

NAPWHA (National Association of people with HIV Australia), July 2021 Despite access to effective ART and viral suppression, people living with HIV often report poor well-being and health-related quality of life. A multidisciplinary panel of 44 global HIV experts articulate how health systems can advance the long-term well-being of people living with HIV by addressing multi-morbidity, health...

FDA Approves Cabenuva, the First Complete Long-Acting Injectable HIV Treatment

F

Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...

U = U: awareness and associations with health outcomes among PLHIV in 25 countries

U

Okoli C, Van de Velde N, Richman B, et al Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries Sexually Transmitted Infections  Published Online First: 30 July 2020. doi: 10.1136/sextrans-2020-054551 Abstract: Objectives ‘Undetectable equals Untransmittable’ (U=U) is an empowering message that may enable people...

Case report: HIV-associated neurocognitive disorder & myelopathy in patient with preserved CD4, but high viral load

C

HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.  Ayele, B.A., Amogne, W. & Gemechu, L. BMC Infect Dis 20, 574 (2020). This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV...

Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know

C

CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories